𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Postprandial hypotension treated with acarbose in a patient with type 1 diabetes mellitus

✍ Scribed by Simona Maule; Mirko Tredici; Antonio Dematteis; Cristina Matteoda; Livio Chiandussi

Publisher
Springer
Year
2004
Tongue
English
Weight
277 KB
Volume
14
Category
Article
ISSN
0959-9851

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Withdrawal of insulin therapy after adju
Withdrawal of insulin therapy after adjunctive treatment with acarbose in a patient with Type 2 diabetes mellitus
✍ Bennett, SMA ;Stewart, MW πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 269 KB

## Abstract Acarbose has been shown to reduce post‐prandial hyperglycaemia and improve glycaemic control in patients with Type 2 diabetes mellitus. We report its use as an adjunct to established insulin therapy in a 64 year old man with Type 2 diabetes mellitus and secondary failure to treatment wi

Case-control study in non-insulin-depend
Case-control study in non-insulin-dependent diabetes mellitus (NIDDM) subjects treated with acarbose
✍ Maria Teresa Guagnano; Fulvio Della Loggia; Valeria Pace-Palitti; Rosa Spoltore; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 2 views

Newer therapeutic approaches are being employed for the treatment of diabetes mellitus, and among these, acarbose, an Ξ±-glucosidase inhibitor, has proven effective in lowering postprandial blood glucose levels and glycosylated hemoglobin. The aim of the present study was to evaluate the effects of